| Annual Free Cash Flow | |
|---|---|
| 2023 | -0.40 |
| 2022 | -6.70 |
| 2021 | -11.06 |
| 2020 | -3.56 |
| Quarterly Free Cash Flow | |
|---|---|
| 2024-09-30 | -1.62 |
| 2024-06-30 | -1.38 |
| 2024-03-31 | -0.48 |
| 2023-12-31 | -0.40 |
| 2023-09-30 | -0.54 |
| 2023-06-30 | -0.44 |
| 2023-03-31 | -0.34 |
| 2022-12-31 | -6.70 |
| 2022-09-30 | -7.08 |
| 2022-06-30 | -4.83 |
| 2022-03-31 | -2.25 |
| 2021-12-31 | -11.06 |
| 2021-09-30 | -5.64 |
| 2021-06-30 | -3.81 |
| 2021-03-31 | -2.69 |
| 2020-12-31 | |
| 2020-09-30 | -2.39 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| $0.000B | $0.000B | ||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bionomics (NEUP) | Australia | $0.007B | 0.00 |
| Kidpik (PIKM) | United States | $0.000B | 0.00 |